FDA Approves Expanded Indication for Edwards Lifesciences’ Transcatheter Valve

FDA Approves Expanded Indication for Edwards Lifesciences’ Transcatheter Valve

[at noodls] – IRVINE, CA, October 19, 2012 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today that it has received approval from … more

View todays social media effects on EW

View the latest stocks trending across Twitter. Click to view dashboard

Share this post